Overview

GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma

Status:
Terminated
Trial end date:
2017-03-22
Target enrollment:
Participant gender:
Summary
GA101-miniCHOP regimen for the treatment of elderly unfit patients with diffuse large B-cell non-Hodgkin's lymphoma.
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione Italiana Linfomi ONLUS
Treatments:
Obinutuzumab